$8.42
+0.31 (+3.82%)
TIC News30 articles
Atlantic International Stock Soars on Dutch Contracts, Going-Concern Warning Looms
Atlantic International Corp. shares surged 202% after winning $430M in Dutch contracts, but a going-concern warning and thin margins highlight high risk.
Iovance Biotherapeutics Stock Surges on $89.7 Million ATM Offering
Iovance shares rose 9.4% after launching an $89.65 million ATM stock sale, as investors balance dilution risks against the potential for accelerated Amtagvi revenue growth.
Viking Therapeutics Surges on Obesity Drug Hopes
Viking Therapeutics shares climbed 6% to $34.30 as investors bet on upcoming Phase 3 data for its obesity drug VK2735, expected in Q3 2026.
Atlantic International Shares Skyrocket on Dutch Deal, Filing Reveals Deepening Losses
Atlantic International stock soared 155% after its Circle8 unit won a $52M Dutch government contract, but the company's latest filing reveals widening losses, heavy debt, and substantial doubt about its ability to continue.
Coherent Surges 9% on AI Optics Demand, CHIPS Act Signals Indium Phosphide Boost
Coherent shares rose 9.2% to $425.38 on a CHIPS Act letter for up to $50M to expand indium phosphide capacity in Texas, highlighting AI data center supply chain concerns amid China's export checks.
Lumentum Rides AI Optical Demand to 6% Gain Despite Nasdaq Weakness
Lumentum shares surged 6.1% to $901.89, driven by a $400M+ optical circuit switch backlog and underappreciated co-packaged optics attach-rate upside, as AI infrastructure stocks attracted buyers.
AbbVie Acquires Apogee Therapeutics for $10.9B in Cash, Bolstering Pipeline
AbbVie announced a $10.9 billion cash acquisition of Apogee Therapeutics, adding a promising eczema treatment to its pipeline as it seeks to offset declining Humira sales.
AbbVie to Acquire Apogee Therapeutics for $10.9 Billion in Cash
Apogee Therapeutics stock jumped 47% after AbbVie agreed to buy the company for $135.11 per share in cash, adding late-stage eczema drug zumilokibart.
Russell Reconstitution Set to Drive SpaceX Stock More Than Geopolitical Tensions
SpaceX (SPCX) joins the Russell 1000 on Friday, with JPMorgan estimating $4 billion in passive demand, potentially overshadowing geopolitical news from Iran.
Verizon Stock Ends Week Lower on Plan Overhaul Skepticism
Verizon shares slid 5.7% to $45.37 in a holiday-shortened week as new simpler plans and fee cuts face investor skepticism over margin impact.
Applied Optoelectronics Slips Amid AI Optics Slowdown and Supply Concerns
Applied Optoelectronics (AAOI) dropped 4.3% to $161.85 in a shortened trading week, pressured by insider-sale filings, a doubled credit line, and management warnings that supply bottlenecks will cap 800G transceiver revenue into mid-2027.
Air Canada Nears 52-Week High Amid Falling Oil Prices and Geopolitical Risks
Air Canada shares closed at C$24.20, up 4.6% and just a cent shy of its 52-week high, driven by lower oil prices. However, the airline has withdrawn its 2026 outlook due to unpredictable fuel costs, and renewed Middle East tensions threaten to push jet fuel higher.
VIX Tumbles as US-Iran Truce Eases Oil Fears, But Political Risk Persists
The VIX dropped 11% to 16.40 as the US-Iran deal eased oil and inflation fears, but canceled talks in Switzerland keep political risk in focus.
Defense Stocks Slide as U.S.-Iran Deal Eases Geopolitical Risk
Lockheed Martin shares dropped 4.1% as defense stocks underperformed a rising market amid a U.S.-Iran interim deal that reduced geopolitical risk, with sector peers also declining.
Nokia Rallies on Lenovo Patent Pact and AI-Driven Optical Expansion
Nokia gained 1.3% to €12.20 on a Lenovo patent pact and optical/defense updates, but undisclosed terms and a 119% YTD surge raise the bar for earnings on July 23.
IceCure Medical Surges on ProSense Uptick and $5.5M Financing
IceCure Medical shares soared 200% after revealing a 70% jump in U.S. ProSense breast cancer cryoablation installs and a $5.5 million private placement, as the market balances rapid adoption against potential dilution.
Snap Stock Plunges 8% on $2,195 AR Spectacles Launch, Investor Skepticism
Snap shares tumbled 8.1% after launching $2,195 Specs AR glasses, as investors question the device's ability to revive growth without draining cash.
Intel Shares Surge on 18A-P Milestone and Server CPU Demand Uptick
Intel shares rose 3.5% to $121.10 after its 18A-P process entered risk production and Bernstein lifted its price target to $100 on improved server CPU demand.
Coherent Stock Slips Despite $50M CHIPS Grant; AI Optics Demand in Question
Coherent shares slipped 1% to $378.85 despite a $50M CHIPS grant for its Texas InP plant, as high valuation and supply risks overshadow AI optics demand.
SoFi CEO Noto Boosts Stake Amid Rate Decision Anticipation
SoFi Technologies CEO Anthony Noto bought 13,888 shares for $251K ahead of the Fed's rate decision, sending the stock up 3.2% to $18.28.
Snap Shares Plunge After $2,195 AR Glasses Launch Sparks Investor Skepticism
Snap shares tumbled 9.63% to $5.16 after launching $2,195 Specs AR glasses, as investors question demand and profitability amid activist pressure.
Nokia Rises on AI Network Expansion Plans; Optical Demand in Focus
Nokia Oyj shares rose 1.17% to €12.15 in Helsinki after unveiling major AI-focused network expansions, including a U.S. photonic-chip packaging facility and a subsea cable upgrade in Southeast Asia.
Halland's Tourism Sector Sees Uptick in International Visitors Ahead of Summer Season
Halland tourism firms report a 14.2% rise in foreign guest nights, outpacing Sweden's 7.7% average, with nearly 70% expecting a good 2026 season.
Roblox Shares Rally 8% on Global Safety Rollout and User Engagement Uptick
Roblox shares jumped 8% to $49.34 after launching global age-based accounts and a TD Cowen note highlighted a 10% weekend rise in concurrent users, as investors assess the impact of safety changes.
Outlook Therapeutics Surges on FDA Review of Wet AMD Treatment
Outlook Therapeutics shares jumped 30% after the FDA accepted its resubmitted BLA for ONS-5010/LYTENAVA, setting a PDUFA target date of July 29, 2026.
Fox Stock Plunges 17% on $22B Roku Acquisition, Investor Skepticism Mounts
Fox shares tumbled 16.8% after agreeing to acquire Roku for $22 billion. The deal raises concerns about debt, dilution, and execution risks.
Intellia Therapeutics Surges 23% on Promising Phase 3 Data for CRISPR Therapy
Intellia Therapeutics shares surged 23% to $14.92 after Phase 3 data showed lonvo-z reduced hereditary angioedema attacks by up to 91% versus placebo, with FDA filing as the next catalyst.
Bitcoin Recaptures $65,700 as Geopolitical Fears Ease; Fed Meeting in Focus
Bitcoin rebounded to $65,717 as geopolitical tensions eased and spot-Bitcoin ETFs saw renewed inflows. The Federal Reserve's upcoming policy meeting is the next key catalyst for crypto markets.
Ford Stock Wavers Near $15 Amid Recalls, Earnings Anticipation
Ford stock remains under pressure near $15 as new recalls of Focus and Expedition models raise quality worries ahead of its Q2 earnings report on July 29.
OpenAI CEO Cancels Abu Dhabi Visit Amid IPO Filing and Geopolitical Tensions
OpenAI CEO Sam Altman canceled a planned trip to Abu Dhabi, raising questions about the company's Stargate infrastructure plans in the UAE as it pursues a $1 trillion IPO valuation.